149 related articles for article (PubMed ID: 35427563)
21. In vivo near-infrared fluorescence imaging of Leishmania amazonensis expressing infrared fluorescence protein (iRFP) for real-time monitoring of cutaneous leishmaniasis in mice.
Oliveira JC; da Silva AC; Oliveira RA; Pereira VR; Gil LH
J Microbiol Methods; 2016 Nov; 130():189-195. PubMed ID: 27498229
[TBL] [Abstract][Full Text] [Related]
22. Topical photodynamic therapy with chloroaluminum phthalocyanine liposomes is as effective as systemic pentavalent antimony in the treatment of experimental cutaneous leishmaniasis.
Lopes SC; Silva RA; Novais MV; Coelho LD; Ferreira LA; Souza PE; Tedesco A; Azevedo RB; Aguiar MG; Oliveira MC
Photodiagnosis Photodyn Ther; 2019 Dec; 28():210-215. PubMed ID: 31454712
[TBL] [Abstract][Full Text] [Related]
23. Immunomodulatory effect of Canova medication on experimental Leishmania amazonensis infection.
Pereira WK; Lonardoni MV; Grespan R; Caparroz-Assef SM; Cuman RK; Bersani-Amado CA
J Infect; 2005 Aug; 51(2):157-64. PubMed ID: 16038768
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of lapachol on treatment of cutaneous and visceral leishmaniasis.
Araújo IAC; de Paula RC; Alves CL; Faria KF; Oliveira MM; Mendes GG; Dias EMFA; Ribeiro RR; Oliveira AB; Silva SMD
Exp Parasitol; 2019 Apr; 199():67-73. PubMed ID: 30797783
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of nanoemulsion with Pterodon emarginatus Vogel oleoresin for topical treatment of cutaneous leishmaniasis.
Kawakami MYM; Zamora LO; Araújo RS; Fernandes CP; Ricotta TQN; de Oliveira LG; Queiroz-Junior CM; Fernandes AP; da Conceição EC; Ferreira LAM; Barros ALB; Aguiar MG; Oliveira AEMFM
Biomed Pharmacother; 2021 Feb; 134():111109. PubMed ID: 33341050
[TBL] [Abstract][Full Text] [Related]
26. Assessing nystatin cream treatment efficacy against Leishmania (L.) amazonensis infection in BALB/c model.
Gonçalves-Oliveira LF; Peixoto JF; Dias-Lopes G; Souza-Silva F; Côrtes LMC; Rocha HVA; Alves CR
Exp Parasitol; 2023 Jul; 250():108547. PubMed ID: 37196701
[TBL] [Abstract][Full Text] [Related]
27. Activity, toxicity and analysis of resistance of essential oil from Chenopodium ambrosioides after intraperitoneal, oral and intralesional administration in BALB/c mice infected with Leishmania amazonensis: a preliminary study.
Monzote L; Montalvo AM; Scull R; Miranda M; Abreu J
Biomed Pharmacother; 2007; 61(2-3):148-53. PubMed ID: 17254746
[TBL] [Abstract][Full Text] [Related]
28. Role of interleukin-4 and prostaglandin E2 in Leishmania amazonensis infection of BALB/c mice.
Guimarães ET; Santos LA; Ribeiro dos Santos R; Teixeira MM; dos Santos WL; Soares MB
Microbes Infect; 2006 Apr; 8(5):1219-26. PubMed ID: 16531090
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of miltefosine treatment in Leishmania amazonensis-infected BALB/c mice.
Godinho JL; Simas-Rodrigues C; Silva R; Ürmenyi TP; de Souza W; Rodrigues JC
Int J Antimicrob Agents; 2012 Apr; 39(4):326-31. PubMed ID: 22226653
[TBL] [Abstract][Full Text] [Related]
30. Intramuscular and topical treatment of cutaneous leishmaniasis lesions in mice infected with Leishmania amazonensis using coumarin (-) mammea A/BB.
Tiuman TS; Brenzan MA; Ueda-Nakamura T; Filho BP; Cortez DA; Nakamura CV
Phytomedicine; 2012 Oct; 19(13):1196-9. PubMed ID: 22954418
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of the 7-chloro-4-(3-hydroxy-benzilidenehydrazo)quinoline derivative against infection caused by Leishmania amazonensis.
Antinarelli LMR; Souza MVN; Coelho EAF; Lima WP; Coimbra ES
Rev Soc Bras Med Trop; 2020; 53():e20200091. PubMed ID: 32578713
[TBL] [Abstract][Full Text] [Related]
32. Leishmania amazonensis: Increase in ecto-ATPase activity and parasite burden of vinblastine-resistant protozoa.
Giarola NL; Silveira TS; Inacio JD; Vieira LP; Almeida-Amaral EE; Meyer-Fernandes JR
Exp Parasitol; 2014 Nov; 146():25-33. PubMed ID: 25176449
[TBL] [Abstract][Full Text] [Related]
33. The combination therapy of meglumine antimoniate and oxiranes (epoxy-α-lapachone and epoxymethyl-lawsone) enhance the leishmanicidal effect in mice infected by Leishmania (Leishmania) amazonensis.
Gonçalves-Oliveira LF; Souza-Silva F; de Castro Côrtes LM; Veloso LB; Santini Pereira BA; Cysne-Finkelstein L; Lechuga GC; Bourguignon SC; Almeida-Souza F; da Silva Calabrese K; Ferreira VF; Alves CR
Int J Parasitol Drugs Drug Resist; 2019 Aug; 10():101-108. PubMed ID: 31430693
[TBL] [Abstract][Full Text] [Related]
34. Biological behavior of Leishmania amazonensis isolated from humans with cutaneous, mucosal, or visceral leishmaniasis in BALB/C mice.
Almeida RP; Barral-Netto M; De Jesus AM; De Freitas LA; Carvalho EM; Barral A
Am J Trop Med Hyg; 1996 Feb; 54(2):178-84. PubMed ID: 8619444
[TBL] [Abstract][Full Text] [Related]
35. Hairless mice as an experimental model of infection with Leishmania (Leishmania) amazonensis.
Araujo VC; Fukutani KF; Oshiro ET; Rodrigues PO; Rizk YS; Carollo CA; Arruda CC
Exp Parasitol; 2015 Oct; 157():138-44. PubMed ID: 26234915
[TBL] [Abstract][Full Text] [Related]
36. Parasite burden in Leishmania (Leishmania) amazonensis-infected mice: validation of luciferase as a quantitative tool.
Reimão JQ; Trinconi CT; Yokoyama-Yasunaka JK; Miguel DC; Kalil SP; Uliana SR
J Microbiol Methods; 2013 May; 93(2):95-101. PubMed ID: 23466934
[TBL] [Abstract][Full Text] [Related]
37. The role of TLR9 on Leishmania amazonensis infection and its influence on intranasal LaAg vaccine efficacy.
Pratti JES; da Fonseca Martins AM; da Silva JP; Ramos TD; Pereira JC; Firmino-Cruz L; Oliveira-Maciel D; Vieira TSS; Lacerda LL; Vale AM; Freire-de-Lima CG; Gomes DCO; Saraiva EM; Rossi-Bergmann B; de Matos Guedes HL
PLoS Negl Trop Dis; 2019 Feb; 13(2):e0007146. PubMed ID: 30802247
[TBL] [Abstract][Full Text] [Related]
38. Treatment using vanillin-derived synthetic molecules incorporated into polymeric micelles is effective against infection caused by Leishmania amazonensis species.
Pereira IAG; Freitas CS; Câmara RSB; Jesus MM; Lage DP; Tavares GSV; Soyer TG; Ramos FF; Soares NP; Santiago SS; Martins VT; Vale DL; Pimenta BL; Ludolf F; Oliveira FM; Duarte MC; Chávez-Fumagalli MA; Costa AV; Gonçalves DU; Roatt BM; Teixeira RR; Coelho EAF
Exp Parasitol; 2024 May; 260():108743. PubMed ID: 38513973
[TBL] [Abstract][Full Text] [Related]
39. The histopathological and immunological pattern of CBA mice infected with Leishmania amazonensis after treatment with pyrazole carbohydrazide derivatives.
Charret KS; Lagrota-Cândido J; Carvalho-Pinto CE; Hottz CF; Lira ML; Rodrigues RF; Gomes AO; Bernardino AM; Canto-Cavalheiro MM; Leon LL; Amaral VF
Exp Parasitol; 2013 Feb; 133(2):201-10. PubMed ID: 23219949
[TBL] [Abstract][Full Text] [Related]
40. Antiparasitic Activity of Two Natural Terpenes from
Troncoso ME; Germanó MJ; Arrieta VJ; García Bustos MF; Cifuente D; Cargnelutti DE; Lozano ES
J Nat Prod; 2023 Apr; 86(4):797-803. PubMed ID: 36857574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
